Receiving a liver transplant from a living donor is associated with an increased risk — as much as four times higher — of disease recurrence…
News
LIVER DISEASE
NewsEarly detection highlighted in this year’s Rare Liver Diseases Month
February is Rare Liver Diseases Month, and this year, the Global Liver Institute (GLI) is highlighting the importance of early diagnosis for better health…
FATTY LIVER DISEASE
NewsApproval of Kayshild, sold in US as Wegovy, urged in EU for treating MASH
A committee of the European Medicines Agency (EMA) has recommended that Kayshild (semaglutide), marketed in the U.S. and Canada as Wegovy, be approved in…
BILIARY ATRESIA
NewsLiver complication linked to transplant need in biliary atresia: Study
Half of biliary atresia patients who have undergone standard Kasai surgery develop a serious liver complication called portal hypertension (PH), and this is linked…
Huahui Health‘s Libevitug has become the first approved treatment for chronic hepatitis D virus (HDV) infection in China. The country’s National Medical Products Administration…
People who are exposed to more sunlight over their lifetimes are less likely to develop primary biliary cholangitis (PBC), a study shows. “This suggests…
An international group of patients, clinicians, and researchers has recommended a standardized set of clinical measurements to assess outcomes in intrahepatic cholestasis of pregnancy…
FATTY LIVER DISEASE
NewsCombination of aerobic, resistance exercise best for reducing liver fat
A combination of aerobic exercise and resistance exercise is most effective for reducing liver fat, according to a review of data from appropriately controlled clinical…
International Alagille Syndrome Awareness Day is tomorrow, Jan. 24, and the advocacy organization Alagille Syndrome Alliance is calling on the community to stand together…
After about two years of treatment with the experimental therapies tobevibart and elebsiran, nearly nine out of 10 evaluable…
Recent Posts
- FDA gives bepirovirsen priority review for chronic hepatitis B
- Starting disease marker levels may shape Iqirvo response in PBC
- The possibility for liver function to improve brings me hope
- New mouse model could help guide PFIC3 treatment research
- “Zombie” immune cells may help drive steatotic liver disease, study shows